VIGLIM TRIO 1/0.2 GLIMEPIRIDE 1mg. IP + METFORMIN 500mg. IP + VOGLIBOSE 0.2mg. IP

Viglim Trio 1/0.2 tablets are used, with diet and exercise, to improve blood glucose control in adults with type 2 diabetes. Main uses: used as an addition to diet and exercise to improve blood glucose control in adults with type 2 diabetes mellitus; helps control fasting blood glucose through glimepiride and metformin; helps control the rise in blood glucose after meals through voglibose; intended for long-term blood glucose management under a doctor's supervision.

Common side effects of Viglim Trio 1/0.2 Tablet include low blood glucose (hypoglycemia), with sweating, shakiness or hunger; nausea, vomiting or stomach discomfort; diarrhoea or loose motions; flatulence, gas or bloating; headache; dizziness or weakness. Get medical help at once if you notice severe hypoglycemia that needs immediate attention; lactic acidosis (rare but serious; symptoms include deep rapid breathing, muscle pain, unusual sleepiness and abdominal pain); serious allergic reactions such as anaphylaxis, angioedema or Stevens-Johnson syndrome.

Each Viglim Trio 1/0.2 tablet contains Glimepiride 1 mg + Metformin 500 mg + Voglibose 0.2 mg. The right dose and how long to take it depend on the condition, age and other medicines, so use Viglim Trio 1/0.2 Tablet only as your doctor advises.

The MRP of Viglim Trio 1/0.2 Tablet is ₹198 for a pack of 10x15 (Blister). For chemists and distributors, the PTR is ₹150.86 and the PTS is ₹135.77.

Each Viglim Trio 1/0.2 tablet contains Glimepiride 1 mg + Metformin 500 mg + Voglibose 0.2 mg. It comes in a pack of 10x15 (Blister).

Each ingredient works in a different way to keep blood glucose under control. Glimepiride encourages the pancreas to release more insulin. Metformin reduces the amount of glucose produced by the liver and helps the body respond more readily to its own insulin. Voglibose slows the digestion and absorption of carbohydrates in the intestine, so the rise in blood glucose after meals is smaller. Together they help control both fasting and after-meal glucose levels.

Must not be used in patients with type 1 diabetes mellitus or diabetic ketoacidosis. Must not be used in patients with severe kidney impairment or with metabolic acidosis. Must not be used if there is a known allergy to glimepiride, metformin, voglibose or any ingredient of the tablet. Must not be used by patients who have had an allergic reaction to sulfonamide derivatives. Check with a doctor first if you have kidney or liver disease, are elderly, drink alcohol heavily, are pregnant or breastfeeding, or take other diabetes medicines.

Viglim Trio 1/0.2 Tablet is a brand of Vibcare Pharma, sold through its Cure division. It is available for PCD pharma franchise and distribution in India; use the Send Enquiry or WhatsApp button on this page to ask about availability and terms.